CIBC Private Wealth Group
BIO icon

CIBC Private Wealth Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

CIBC Private Wealth Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$49.7K Sell
164
-167
-50% -$52.1K ﹤0.01% 1781
2025
Q3 		$92.8K Buy
331
+234
+241% +$63.7K ﹤0.01% 1527
2025
Q2 		$23.4K Sell
97
-41,313
-100% -$9.77M ﹤0.01% 1959
2025
Q1 		$9.13M Sell
41,410
-696
-2% -$209K 0.02% 334
2024
Q4 		$14.5M Sell
42,106
-1,243
-3% -$422K 0.03% 302
2024
Q3 		$14.5M Buy
43,349
+137
+0.3% +$43.5K 0.03% 311
2024
Q2 		$11.9M Sell
43,212
-480
-1% -$140K 0.02% 304
2024
Q1 		$14.8M Buy
43,692
+405
+0.9% +$133K 0.03% 291
2023
Q4 		$14M Buy
+43,287
New +$13.6M 0.03% 282
2018
Q4 		– Sell
-5,612
Closed -$1.76M – 870
2018
Q3 		$1.76M Buy
+5,612
New +$1.74M 0.01% 545
2018
Q1 		– Sell
-9
Closed -$2K – 1942
2017
Q4 		$2K Buy
+9
New +$2.18K ﹤0.01% 1804

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return